Botulinum toxin efficacy and safety in geriatric patients with overactive bladder: Turkish first multicenter study

被引：0
|
作者：
Karakeci, A. [2 ]
Keles, A. [1 ]
Onur, R. [3 ]
机构：
[1] Istanbul Esenyurt State Hosp, Istanbul, Turkey
[2] Firat Univ, Sch Med, Elazig, Turkey
[3] Marmara Univ, Sch Med, Istanbul, Turkey
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2019年 / 26卷
关键词：
overactive bladder; botulinum neurotoxin A; quality of life; geriatric patients;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
490
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [41] A systematic review and meta-analysis of effectiveness and safety of therapy for overactive bladder using botulinum toxin A at different dosages
    Gu, Hui-Yun
    Song, Ju-Kun
    Zhang, Wen-Jun
    Xie, Jin
    Yao, Qi-Sheng
    Zeng, Wen-Jing
    Zhang, Chao
    Niu, Yu-Ming
    ONCOTARGET, 2017, 8 (52) : 90338 - 90350
  • [42] Non-invasive evaluation of botulinum-A toxin treatment efficacy in children with refractory overactive bladder
    Ucar, Murat
    Akgul, Ahsen Karagozlu
    Parlak, Ayse
    Yucel, Cem
    Kilic, Nizamettin
    Balkan, Emin
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (08) : 1367 - 1373
  • [43] Medium- to long-term outcomes of botulinum toxin A for idiopathic overactive bladder
    Eldred-Evans, David
    Sahai, Arun
    THERAPEUTIC ADVANCES IN UROLOGY, 2017, 9 (01) : 3 - 10
  • [44] Mirabegron in Overactive Bladder: A Review of Efficacy, Safety, and Tolerability
    Chapple, Christopher R.
    Cardozo, Linda
    Nitti, Victor W.
    Siddiqui, Emad
    Michel, Martin C.
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (01) : 17 - 30
  • [45] Non-invasive evaluation of botulinum-A toxin treatment efficacy in children with refractory overactive bladder
    Murat Uçar
    Ahsen Karagözlü Akgül
    Ayşe Parlak
    Cem Yücel
    Nizamettin Kılıç
    Emin Balkan
    International Urology and Nephrology, 2018, 50 : 1367 - 1373
  • [46] Hengli(R) Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
    Liao, Limin
    Liu, Qinggang
    Cong, Huiling
    Xu, Zhihui
    Li, Enhui
    Weng, Zhiliang
    Jiang, Haihong
    Liu, Ben
    Huang, Xiao
    Xia, Shujie
    Wen, Wei
    Wu, Juan
    Shi, Guowei
    Wang, Yang
    Li, Peijun
    Yu, Yang
    Fang, Zujun
    Zheng, Jie
    Tian, Ye
    Shang, Donghao
    Li, Hanzhong
    Huang, Zhongming
    Zhou, Liqun
    Xiao, Yunxiang
    Zhang, Yaoguang
    Wang, Jianlong
    Zhang, Xiaodong
    Zhang, Peng
    Wang, Dongwen
    Zhang, Xuhui
    Xie, Keji
    Wang, Bin
    Ma, Lulin
    Tian, Xiaojun
    Chen, Lijun
    Dong, Jinkai
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] Women’s perspective of botulinum toxin treatment for overactive bladder symptoms
    G. Alessandro Digesu
    Demetri Panayi
    Caroline Hendricken
    Michelle Camarata
    Ruwan Fernando
    Vikram Khullar
    International Urogynecology Journal, 2011, 22 : 425 - 431
  • [48] Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
    Sahai, Arun
    Sangster, Philippa
    Kalsi, Vinay
    Khan, Mohammad S.
    Fowler, Clare J.
    Dasgupta, Prokar
    BJU INTERNATIONAL, 2009, 103 (05) : 630 - 634
  • [49] Efficacy and Safety of Propiverine and Solifenacin for the Treatment of Female Patients with Overactive Bladder: A Crossover Study
    Wada, Naoki
    Watanabe, Masaki
    Kita, Masafumi
    Osanai, Hiroaki
    Yamaguchi, Satoshi
    Numata, Atsushi
    Kakizaki, Hidehiro
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2011, 3 (01) : 36 - 42
  • [50] Intravesical botulinum toxin for overactive bladder syndrome without detrusor overactivity
    Jackson, B. L.
    Burge, F.
    Bronjewski, E.
    Parkinson, R. J.
    JOURNAL OF CLINICAL UROLOGY, 2012, 5 (04) : 169 - 173
12345